American Century Companies Inc Xenon Pharmaceuticals Inc. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$36.25 - $43.75 $133,255 - $160,825	-3,676 Reduced 38.07%	5,979 $233,000
Q1 2024 May 14, 2024	BUY	$42.66 - $50.04 $104,772 - $122,898	2,456 Added 34.12%	9,655 $415,000
Q4 2023 Feb 13, 2024	BUY	$28.7 - $46.46 $206,611 - $334,465	7,199 New	7,199 $331,000
Q1 2023 May 11, 2023	SELL	$33.46 - $40.35 $51,227 - $61,775	-1,531 Reduced 13.91%	9,474 $339,000
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $143,315 - $170,929	4,335 Added 64.99%	11,005 $433,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $205,369 - $265,599	6,670 New	6,670 $241,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.